Ignite Creation Date:
2025-12-24 @ 10:31 PM
Ignite Modification Date:
2026-01-01 @ 11:09 AM
Study NCT ID:
NCT05687435
Status:
UNKNOWN
Last Update Posted:
2023-01-18
First Post:
2022-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
Sponsor:
Mei Han
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-23
First Submit QC Date:
None
Study First Post Date:
2023-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-13
Last Update Post Date:
2023-01-18
Last Update Post Date Type:
ACTUAL